REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PuriBlood Medical Co.,Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PuriBlood Medical Co.,Ltd. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

PuriBlood Medical Co.,Ltd. is committed to the development and application of double ion materials. The company was founded in 2016 and headquartered in Hsinchu City, Taiwan.

Headquarters
2F, No.11, Gongye E. 9Th Rd, Baoshan Township
Hsinchu City; Hsinchu City;

Contact Details: Purchase the PuriBlood Medical Co.,Ltd. report to view the information.

Website: http://puriblood.com

Basic Information
Total Employees:
Purchase the PuriBlood Medical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the PuriBlood Medical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the PuriBlood Medical Co.,Ltd. report to view the information.
Incorporation Date:
January 27, 2016
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
11.88%
Purchase this report to view the information.
7.36%
Purchase this report to view the information.
6.59%
Purchase this report to view the information.
6.52%
Purchase this report to view the information.
Subsidiaries
G-Feng Biotechnology CO., Ltd.
40%
Huixu Technology Co., Ltd.
25%
Micronbrane Medical Company Limited
12.87%
Company Performance
Financial values in the chart are available after PuriBlood Medical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
4.01%▲
Total operating revenue
6.14%▲
Operating profit (EBIT)
29.82%▲
EBITDA
44.89%▲
Net Profit (Loss) for the Period
32%▲
Total assets
-20.62%▼
Total equity
-21.43%▼
Operating Profit Margin (ROS)
21.03%▲
Net Profit Margin
19.58%▲
Return on Equity (ROE)
1.14%▲
Debt to Equity Ratio
18.7%▲
Quick Ratio
-0.27%▼
Cash Ratio
0.81%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo